These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 33990606)

  • 21. Can the Microbiome Deliver? A Proof-of-Concept Engineered E. coli PKU Therapeutic.
    Alteri CJ
    Cell Host Microbe; 2019 Apr; 25(4):473-474. PubMed ID: 30974078
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dealing with the genetic load in bacterial synthetic biology circuits: convergences with the Ohm's law.
    Carbonell-Ballestero M; Garcia-Ramallo E; Montañez R; Rodriguez-Caso C; Macía J
    Nucleic Acids Res; 2016 Jan; 44(1):496-507. PubMed ID: 26656950
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A complex human gut microbiome cultured in an anaerobic intestine-on-a-chip.
    Jalili-Firoozinezhad S; Gazzaniga FS; Calamari EL; Camacho DM; Fadel CW; Bein A; Swenor B; Nestor B; Cronce MJ; Tovaglieri A; Levy O; Gregory KE; Breault DT; Cabral JMS; Kasper DL; Novak R; Ingber DE
    Nat Biomed Eng; 2019 Jul; 3(7):520-531. PubMed ID: 31086325
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microfluidics in male reproduction: is ex vivo culture of primate testis tissue a future strategy for ART or toxicology research?
    Sharma S; Venzac B; Burgers T; Le Gac S; Schlatt S
    Mol Hum Reprod; 2020 Mar; 26(3):179-192. PubMed ID: 31977028
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dynamic in vitro intestinal barrier model coupled to chip-based liquid chromatography mass spectrometry for oral bioavailability studies.
    Santbergen MJC; van der Zande M; Gerssen A; Bouwmeester H; Nielen MWF
    Anal Bioanal Chem; 2020 Feb; 412(5):1111-1122. PubMed ID: 31865418
    [TBL] [Abstract][Full Text] [Related]  

  • 26. "Good Fences Make Good Neighbors": How does the Human Gut Microchip Unravel Mechanism of Intestinal Inflammation?
    Shin W; Hackley LA; Kim HJ
    Gut Microbes; 2020 May; 11(3):581-586. PubMed ID: 31198078
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Harvesting of Prebiotic Fructooligosaccharides by Nonbeneficial Human Gut Bacteria.
    Wang Z; Tauzin AS; Laville E; Tedesco P; Létisse F; Terrapon N; Lepercq P; Mercade M; Potocki-Veronese G
    mSphere; 2020 Jan; 5(1):. PubMed ID: 31915220
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthetic Biology and the Gut Microbiome.
    Dou J; Bennett MR
    Biotechnol J; 2018 May; 13(5):e1700159. PubMed ID: 28976641
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Integration of microfluidics into the synthetic biology design flow.
    Huang H; Densmore D
    Lab Chip; 2014 Sep; 14(18):3459-74. PubMed ID: 25012162
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Models of the Gut for Analyzing the Impact of Food and Drugs.
    Fois CAM; Le TYL; Schindeler A; Naficy S; McClure DD; Read MN; Valtchev P; Khademhosseini A; Dehghani F
    Adv Healthc Mater; 2019 Nov; 8(21):e1900968. PubMed ID: 31592579
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Computer model of the metabolism of phenylalanine in normal subjects and in patients with phenylketonuria.
    Hjelm M; Kitney R; Lindsey P; Seakins J
    Comput Programs Biomed; 1984; 18(1-2):21-31. PubMed ID: 6547653
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combinatory biotechnological intervention for gut microbiota.
    Khangwal I; Shukla P
    Appl Microbiol Biotechnol; 2019 May; 103(9):3615-3625. PubMed ID: 30847544
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overloaded and stressed: whole-cell considerations for bacterial synthetic biology.
    Borkowski O; Ceroni F; Stan GB; Ellis T
    Curr Opin Microbiol; 2016 Oct; 33():123-130. PubMed ID: 27494248
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Developing a new class of engineered live bacterial therapeutics to treat human diseases.
    Charbonneau MR; Isabella VM; Li N; Kurtz CB
    Nat Commun; 2020 Apr; 11(1):1738. PubMed ID: 32269218
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthetic Biology Approaches in The Development of Engineered Therapeutic Microbes.
    Kang M; Choe D; Kim K; Cho BK; Cho S
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33228099
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A quantitative model for metabolic intervention using gut microbes.
    Mays ZJS; Nair NU
    Biotechnol Prog; 2021 Sep; 37(5):e3125. PubMed ID: 33426814
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Short-term supplementation of celecoxib-shifted butyrate production on a simulated model of the gut microbial ecosystem and ameliorated in vitro inflammation.
    Hernandez-Sanabria E; Heiremans E; Calatayud Arroyo M; Props R; Leclercq L; Snoeys J; Van de Wiele T
    NPJ Biofilms Microbiomes; 2020 Feb; 6(1):9. PubMed ID: 32075981
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Advances of microfluidic intestine-on-a-chip for analyzing anti-inflammation of food.
    Liang D; Su W; Tan M
    Crit Rev Food Sci Nutr; 2022; 62(16):4418-4434. PubMed ID: 33480263
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SYNTHETIC BIOLOGY. Emergent genetic oscillations in a synthetic microbial consortium.
    Chen Y; Kim JK; Hirning AJ; Josić K; Bennett MR
    Science; 2015 Aug; 349(6251):986-9. PubMed ID: 26315440
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Establishment of a Modular Anaerobic Human Intestine Chip.
    Jalili-Firoozinezhad S; Bein A; Gazzaniga FS; Fadel CW; Novak R; Ingber DE
    Methods Mol Biol; 2022; 2373():69-85. PubMed ID: 34520007
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.